CClinicalTrials.gg
CompletedNCT00123513Updated Jun 13, 2012

Workplace-Sponsored Program to Reduce Obesity

An interventional study of Diet and Exercise in Obesity and Cardiovascular Diseases, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-06-13.

Sponsored by University of Rochester · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
3,938
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to design a comprehensive nutrition and physical activity strategy to gain a broad understanding of the social and cultural role of food and physical activity among workers. Perspectives on innovative interventions that are socially feasible and culturally acceptable will also be obtained. Health lifestyle promotion interventions addressing portion control, healthy nutrition, and increasing physical activity will be tested.

Read the detailed description

BACKGROUND:

Broad, population-based approaches are needed to stop or reverse the rise in obesity prevalence. According to the World Health Organization, obesity prevention can be achieved by promoting a healthy diet and a physically active lifestyle. A partnership with the Eastman Kodak Company has been developed to test a worksite intervention for obesity prevention in Rochester, New York.

DESIGN NARRATIVE:

The overall goal of this study is to design a comprehensive nutrition and physical activity strategy based on participatory research to promote a healthy lifestyle and to stop the shift of the population body mass index (BMI) curve to the right. Six pairs of worksites will be randomized to either an intervention or control group. Two cross-sectional samples of employees within each worksite will be measured at baseline and at the end of the intervention.

02

Conditions studied

  • Obesity
  • Cardiovascular Diseases
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 3,938 is above the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Full-time employees in good health
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,938 participants (actual)

Study arms

  • Experimental
    1

    Worksite intervention for obesity prevention

    Behavioral: Diet · Behavioral: Exercise · Behavioral: Environment

  • No intervention
    2

    Control group

Interventions

  • BehavioralDiet

    Environmental changes in the food and physical activity environment. Cafeteria and vending machine changes, food brought from home, walking routes, and awareness building.

    Also known as: Obesogenic environment

  • BehavioralExercise

    Increase routing physical activity, walking routes, stairs intervention, etc.

  • BehavioralEnvironment

    Cafeteria and vending machine changes and identification of opportunities of physical activity.

06

What researchers measure

Primary outcomes

  1. BMI

    Time frame: Measured at baseline and Year 2

Secondary outcomes

  1. Number of serving of fruits and vegetables

    Time frame: Measured at baseline and Year 2

  2. Number of steps a day

    Time frame: Measured at baseline and Year 2

07

Study locations

1 site
  • Eastman Kodak Company
    Rochester, New York, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00123513
Lead sponsor
University of Rochester
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Diana Fernandez (Associate Professor, Department of Community and Preventive Medicine, University of Rochester) — Principal investigator
First posted
Jul 25, 2005
Start date
Sep 2004
Primary completion
Jul 2009
Completion
Jul 2009
Last update
Jun 13, 2012

Study contacts

Isabel D. Fernandez, MD, MPH, PhD
principal investigator · University of Rochester

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion